Regeneron (NASDAQ: REGN) reported Q3 EPS of $11.83, $2.19 better than the analyst estimate of $9.64. Revenue for the quarter came in at $3.75 billion versus the consensus estimate of $3.59 billion.

For earnings history and earnings-related data on Regeneron (REGN) click here.